McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine
- Dow hits milestone, S&P breaks record high on tech rally
- Thermo Fisher Scientific (TMO) to Acquire PPD, Inc. (PPD) for $47.50/sh, $17.4 Billion
- U.S. retail sales post largest gain in 10 months; weekly jobless claims fall
- Dell (DELL) Gains on Spin-Off of its 81% Stake in VMware (VMW), Analysts Bulled-Up as It Could Unlock $20 Per Share of Value for DELL
- The Stock Market is Almost 'Completely Broken' - Einhorn
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Reuters) - U.S. drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine.
The vaccine became the third authorized COVID-19 vaccine in the United States over the weekend, following Friday's unanimous endorsement by the Food and Drug Administration's panel of outside experts.
McKesson is the partner for the U.S. government's COVID-19 vaccine distribution and the company has established four distribution centers which will be specifically used to distribute the Johnson & Johnson COVID-19 vaccine.
The U.S. government makes the administration decisions, including where, when and how many vaccine doses McKesson will distribute, the company said.
Initial deliveries of the vaccine should begin on Tuesday, senior Biden administration officials had said on Sunday.
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fauci says he believes J&J vaccine will 'get back on track soon'
- BOJ's Kuroda signals room to debate monetary policy role in climate change
- CDC Panel on J&J (JNJ) Shot Concludes Without Vote, More Data Needed - Bloomberg
Create E-mail Alert Related CategoriesGeneral News, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!